Omalizumab is a humanized monoclonal antibody designed to target and bind to human immunoglobulin E (IgE). It is widely used in research to study allergic asthma and chronic spontaneous urticaria, facilitating both in vitro binding assays and in vivo models of allergic disease.
Concentration:
75.4 mg/mL
Molecular Weight:
149 kDa
Purity:
99.60% (May vary between batches)
CAS Number:
[242138-07-4]
Target:
Others,Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted